A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
D000336:Aerosols; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002396:Catechols / Q000627:therapeutic use; D004646:Emphysema / Q000188:drug therapy; D004983:Ethanolamines / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D013997:Time Factors
D000336:Aerosols; D001993:Bronchodilator Agents; D002396:Catechols; D004983:Ethanolamines; D010627:Phenethylamines; D010919:Placebos; D009921:Metaproterenol; D010100:Oxygen